BONEBANK will establish a German-Danish biobank for stem cells in bone healing
Currently, bone material which contain valuable stem cells are disposed as surgical waste material during fracture-related routine operations. However, the stem cells have a high potential for regenerative therapies as for instance in the bone healing. BONEBANK aims at harvesting these stem cells with new instruments and methods and to store them in a cross-border biobank. Therefore, this useful resource can be used for therapeutic purposes or for the development of new therapies.
The project partners from Germany and Denmark work together I) to develop a procedure for harvesting bone stem cells in the clinical treatment of bone healing during routine operations, II) to build a German-Danish biobank for stem cells located in Lübeck and Odense, III) to create an organisational and exploitation model for the biobank and providing access to stem cells for patients, public research and companies.
BONEBANK addresses various target audiences:
- Clinicians and hospitals implement the BONEBANK approach to harvest bone stem cells during routine operations.
- Public and/ or private biobank operators are part of the BONEBANK value chain to store and market stem cells.
- Public researchers use bone stem cells for clinical research.
- Life-Science-Industry (Medtech, Biotech, and Pharma) purchase bone stem cells for research and the development of therapies.
- Politicians and general public understand the potentials of bone stem cells for regenerative medicine and the value of the BONEBANK network for the cross-border region.
BONEBANK is funded within the Interreg programme Deutschland-Danmark with means of the European Regional Development Fund. The total budget is EUR 2.4 million during 36 months.
Project partners are the university hospitals in Odense (Denmark) and Lübeck (Germany) as well as the companies Stryker Trauma (orthopaedic products and services), soventec (software solutions for the life sciences) and the cluster organisation Life Science Nord Management. They are supported by the network partners Health Innovation Centre of Southern Denmark and WelfareTech.
For more information see www.bonebank.eu
20 September 2018
Bioagora 2018 (Copenhagen)
19 September 2018
STZ OcuTox: Drug development know-how